2022
DOI: 10.1093/ijnp/pyac038
|View full text |Cite
|
Sign up to set email alerts
|

Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear

Abstract: Background Hyperconsolidation of aversive associations and poor extinction learning have been hypothesized to be crucial in the acquisition of pathological fear. Previous animal and human research points to the potential role of the catecholaminergic system, particularly noradrenaline and dopamine, in acquiring emotional memories. Here, we investigated in a between-subjects design with three groups whether the noradrenergic alpha-2 adrenoreceptor antagonist yohimbine and the dopaminergic D2-r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 137 publications
0
3
0
Order By: Relevance
“…For statistical analysis, we calculated the mean IBI signal between 2000 and 5000 ms relative to stimulus onset. This time range was chosen based on previous studies demonstrating fear bradycardia (slowing of the heartbeat) during the presentation of threat‐predictive cues (Panitz et al, 2015; Sperl et al, 2022). Mean IBI values were imported to R for statistical analysis.…”
Section: Methodsmentioning
confidence: 99%
“…For statistical analysis, we calculated the mean IBI signal between 2000 and 5000 ms relative to stimulus onset. This time range was chosen based on previous studies demonstrating fear bradycardia (slowing of the heartbeat) during the presentation of threat‐predictive cues (Panitz et al, 2015; Sperl et al, 2022). Mean IBI values were imported to R for statistical analysis.…”
Section: Methodsmentioning
confidence: 99%
“…Similar contradictions are observed in humans, such that administration of a D 2 ‐like receptor antagonist prior to or after fear acquisition decreased fMRI BOLD activity in the mPFC towards the CS+ during extinction training, displaying an opposite neuroimaging phenotype to those administered the extinction facilitator L‐DOPA. However, electroencephalography, galvanic skin conductance responses and explicit ratings were unaltered (Klass et al, 2021; Lissek et al, 2015; Sperl et al, 2022). Furthermore, those administered a D 2 ‐like receptor agonist after acquisition exhibited exaggerated renewal as explicit ratings towards the CS+ increased (Lissek et al, 2018).…”
Section: Resultsmentioning
confidence: 99%
“…Humans administered a D 2 -like receptor antagonist tiapride or sulpiride prior to or after acquisition exhibited decreased fMRI BOLD activity in the PFC towards the CS+ during extinction, but EEG, galvanic skin conductance responses, and explicit ratings were unaltered (Klass et al, 2021;Lissek et al, 2015;Sperl et al, 2022). In humans administered a D 2 -like receptor agonist after acquisition, fMRI BOLD activity in the hippocampus increased during extinction and renewal, and explicit ratings towards the CS+ increased during renewal (Lissek et al, 2018).…”
Section: Evidence From Non-selective D 2 -Like Receptor Drug Interven...mentioning
confidence: 98%